December 21, 2014 5:08 AM ET

Healthcare Equipment and Supplies

Company Overview of Adarza BioSystems, Inc.

Company Overview

Adarza BioSystems, Inc. develops optical label-free multiplex sensors for rapid quantitative detection of analyte binding events for application in life science and clinical research, defense, food safety, and medical diagnostics. Its chip-based platform, Arrayed Imaging Reflectometry, achieves high sensitivity by detecting intensity changes in images of antireflective chips functionalized with highly specific detection molecules. The company was formerly known as Pathologics Associates, Inc. Adarza BioSystems, Inc. was founded in 2008 and is based in West Henrietta, New York.

150 Lucius Gordon Drive

Suite 100

West Henrietta, NY 14586

United States

Founded in 2008

Phone:

585-214-2406

Key Executives for Adarza BioSystems, Inc.

Chief Executive Officer and Member of The Board of Directors
Co-founder and Chief Operating Officer
Chief Technology Officer and Member of Science Advisory Board
Compensation as of Fiscal Year 2014.

Adarza BioSystems, Inc. Key Developments

Horizon Discovery and Adarza Enter into Licensing and Supply Agreement

Horizon Discovery Group plc and Adarza BioSystems, Inc., have entered into an exclusive licensing and supply agreement. The agreement gives Horizon the exclusive right to supply services on Adarza's breakthrough multiplex immunoassay technology, Arrayed Imaging Reflectometry (AIR). The technology offers a powerful tool for stratification of patients and samples based on very small blood volumes, an increasingly vital step in the development of personalized medicines. The agreement with Adarza means that Horizon customers will be able to access leading protein biomarker discovery and validation capabilities alongside the broad menu of technology enabled services already available including; in vitro and in vivo gene-editing, phenotypic cell-based assay development, target identification and validation, chemical and biological agent screening, and high throughput drug combination screening. Through this agreement, Horizon gains exclusive rights to offer research services using Adarza's multiplex immunoassays platform, and in 2015 will launch a portfolio of products capable of detecting between 100 and 400 analytes and further to this will offer custom assay development on the platform.

Horizon Discovery Group plc and Adarza Biosystems, Inc. Enter a Exclusive Licensing and Supply Agreement

Horizon Discovery Group plc and Adarza BioSystems, Inc. announced that they have entered into a exclusive licensing and supply agreement. The agreement gives Horizon the exclusive right to supply services on Adarza's breakthrough multiplex immunoassay technology, Arrayed Imaging Reflectometry (AIR). The technology offers a powerful tool for stratification of patients and samples based on very small blood volumes, an increasingly vital step in the development of personalized medicines. The agreement with Adarza means that Horizon customers will be able to access leading protein biomarker discovery and validation capabilities alongside the broad menu of technology enabled services already available including; in vitro and in vivo gene-editing, phenotypic cell-based assay development, target identification and validation, chemical and biological agent screening, and high throughput drug combination screening. Horizon continues to provide researchers with comprehensive solutions that support and enhance their drug development workflows. Through this agreement, Horizon gains exclusive rights to offer research services using Adarza's multiplex immunoassays platform, and in 2015 will launch a portfolio of products capable of detecting between 100 and 400 analytes and further to this will offer custom assay development on the platform. AIR technology enables scientists for the first time to quickly and economically interrogate samples for very large sets of putative biomarkers simultaneously, in sample volumes as low as 10ul, and with sensitivities as low as 1pg/ml, opening up new opportunities for longitudinal studies in pre-clinical models and human samples.

Adarza Appoints Preston Keller as Vice President of Business Development

Adarza announced that in St. Louis, the company has hired Preston Keller as vice president of business development.

Similar Private Companies By Industry

Company Name Region
Hirsch Optical Corp. United States
Noble Medical, Inc. United States
Medinet, Inc. United States
Denta Systems, LLC United States
Peter Brasseler Holdings, L.P. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 18, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adarza BioSystems, Inc., please visit www.adarzabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.